Related references
Note: Only part of the references are listed.NKILA inhibits NF-kappa B signaling and suppresses tumor metastasis
Shun Ke et al.
AGING-US (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Regulation of senescence escape by the cdk4-EZH2-AP2M1 pathway in response to chemotherapy
Melanie Le Duff et al.
CELL DEATH & DISEASE (2018)
Pharmacological inhibition of EZH2 disrupts the female germline epigenome
Lexie Prokopuk et al.
CLINICAL EPIGENETICS (2018)
Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway
Zhiliang Lu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features
Shuangping Guo et al.
DIAGNOSTIC PATHOLOGY (2016)
Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer
Cortney L. Lawrence et al.
PLOS ONE (2016)
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
Horacio Cardenas et al.
ONCOTARGET (2016)
Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition
Wei Huang et al.
ONCOTARGET (2016)
The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
Ji-Yeon Kim et al.
SCIENTIFIC REPORTS (2016)
Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis
Xu Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis
Bodu Liu et al.
CANCER CELL (2015)
NF-κB Expression and Outcomes in Solid Tumors A Systematic Review and Meta-Analysis
Dang Wu et al.
MEDICINE (2015)
The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer
Jianchun Wu et al.
ONCOLOGY REPORTS (2015)
Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis
Arnoud J. Templeton et al.
CANCER TREATMENT REVIEWS (2014)
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
Bisrat G. Debeb et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Canonical and non-canonical roles of the histone methyltransferase EZH2 in mammary development and cancer
Woo Kyun Bae et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells
M. F. Kendellen et al.
ONCOGENE (2014)
EZH2 expands breast stem cells through activation of NOTCH1 signaling
Maria E. Gonzalez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Basal-Like and Triple-Negative Breast Cancers Searching for Positives Among Many Negatives
Prasanna Alluri et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2014)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
EZH2 promotes a bi-lineage identity in basal-like breast cancer cells
R. Z. Granit et al.
ONCOGENE (2013)
Stromal EGF and IGF-I Together Modulate Plasticity of Disseminated Triple-Negative Breast Tumors
Zafira Castano et al.
CANCER DISCOVERY (2013)
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression
Sharon Hensley Alford et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes
Karolina Holm et al.
MOLECULAR ONCOLOGY (2012)
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Shuet Theng Lee et al.
MOLECULAR CELL (2011)
NF-kappa B, stem cells and breast cancer: the links get stronger
Kateryna Shostak et al.
BREAST CANCER RESEARCH (2011)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion
Manran Liu et al.
CANCER RESEARCH (2010)
NF-κB and cancer: how intimate is this relationship
Sahdeo Prasad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Constitutive activation of nuclear factor-kappa B is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines
Noritaka Yamaguchi et al.
CANCER SCIENCE (2009)
NF-κB and Estrogen Receptor α Interactions: Differential Function in Estrogen Receptor-Negative and -Positive Hormone-independent Breast Cancer Cells
Nathalie Gionet et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
Xiaohua Shen et al.
MOLECULAR CELL (2008)
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells
Bin Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain
Diane Palmieri et al.
CANCER RESEARCH (2007)
Activation of nuclear factor-κ B is linked to resistance to neloadjuvant chemotherapy in breast cancer patients
C. Montagut et al.
ENDOCRINE-RELATED CANCER (2006)
Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer
K Collett et al.
CLINICAL CANCER RESEARCH (2006)
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
IM Bachmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The NFκB pathway and endocrine-resistant breast cancer
Y Zhou et al.
ENDOCRINE-RELATED CANCER (2005)
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
MA Huber et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
